SalesTrax.com Research: Quest Diagnostics

Articles found below have been submitted through various PR and news sources and don’t necessary reflect the views of SalesTrax or its employees.

PR Newswire

2009-09-23 12:00
Quest Diagnostics Empowers the Nation's Physicians to Immediately Embrace ePrescribing

2009-09-11 12:00
Quest Diagnostics To Speak at the Bank of America Merrill Lynch Global Healthcare Conference

2009-09-04 12:00
Quest Diagnostics Marks Sixth Year on Dow Jones Sustainability Index

2009-07-24 16:00
FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

2009-07-20 12:00
Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange (NYCLIX) to Share Meaningful Data and Enhance Patient Care

2009-06-24 12:00
Quest Diagnostics Earns Platinum Honor As 'Best Employer For Healthy Lifestyles'

2009-06-22 08:00
Quest Diagnostics HemoCue Subsidiary to Add U.S. Hospital Laboratory Connectivity to Its HemoCue 201 DM Point-of-Care Systems

2009-06-17 12:00
Quest Diagnostics Announces Final Tender Offer Results

2009-06-12 16:00
Quest Diagnostics Announces Pricing of Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes

2009-06-12 12:00
New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance

2009-06-03 16:00
Quest Diagnostics India Recognized as Laureate by the Computerworld Honors Program

2009-06-01 16:00
Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS, NRAS, and BRAF Gene Mutations in Reflex Testing Service


Pharmaceutical Business Review

2009-07-28 04:03
FDA Grants Authorization Of Commercial 2009 H1N1 Flu Test To Quest Diagnostics
Test targets two separate regions of hemagglutinin gene of the virus to differentiate the presence of pandemic virus from seasonal human influenza A virus

2009-07-22 12:04
Quest Diagnostics Reports Strong Q2 Performance
Reported net revenues of $1.9 billion, a rise of 3.5%